Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
APVO...................................................https://stockcharts.com/h-sc/ui?s=APVO&p=W&b=5&g=0&id=p86431144783
APVO looking sweet in afterhours trading.
Also bought in today.
1500 @.95
Let's hope for the best.
Looks like APVO is coming off the bottom
Bought some EOD...
GhosT
Sue for a run again this week.
APVO: effective March 6,2024 a one for 44 reverse split:
https://hedgefollow.com/upcoming-stock-splits.php
What news would turn this turd into gold? It's complete junk at this point and I would almost guarantee the RS will be at 44 to 1.
Went from a promising company when I bought in to nothing but junk.
Just traded in six figures at .150001, does a hedge fund have inside information on news coming?
$APVO
Another turd who can't do actual work to increase the value so let's just do a RS so it looks better to those who haven't dealt with this crapper before. VOTE NO ACROSS THE BOARD IF YOU GET A BALLOT.
It’s a mystery to me why we’re not trading at ten times our current level.
$APVO!!
still red today - hope green still today
APVO SHOULD RISING - YESTERDAY ALREADY $0.49
imho
...then it's time to start a huge recovery today.
imho
TIME TO BOUNCING , LET'S GOOOOO
imho
Alliance Global Partners initiated coverage on Aptevo on October 9th, 2023 at $4.75/ share.
Thanks for the umpteenth update! Company has compounds proven efficacious vs. cancer/leukemia, that’s why it spiked to $70 a couple of years ago. If APVO runs in the near future, remember the warrants/ APVTW…
$APVO
It really does need some good news but I've been nibbling at these cheap shares, I have some healthy positions in the warrants which should also skyrocket on upward moves of the commons
Poco a poco ( Little by little)
I added in a few accounts as it dropped so news and parabolic would be fantastic
It’s going up! News could send this parabolic.
What the hell is going on with APVO? Seems to be a bottomless pit.
Dang, they are still beatin this thing down like a cigarette thief in a convenience store by an employee with a beatin stick.
It appears the offering was priced fairly, did not drop as far as I expected.
Added in all accounts
Great place to add on the offering mayhem
I'm up 40% on my few days of owning APVO - Hoping to hold til it gains me 300% or better.
I have a bunch of bait in the water for the warrants - I really want to add to what I gots.
I scarfed those .015s a while back after wildly overpaying close to $2. Might try a bid at .015..
$APVO// $APVTW
I was shocked that it filled, I usually bid too low to catch these things.
Still trying to lowball the warrants but those are harder to catch where I'm fishin my bait.
Think I'll toss my NFLX gains from today into a split between commons and more warrants. I've already banked huge gains on the warrants way way back, like years ago I think.
Exactly, like today, home run news and it tanks. Why? Clearly being accumulated by deep pockets, because they know the science is tight. APTVW warrants are the high risk/ monster return play..
JMHO
$APVO/$APVTW
It never does for those that hold....
Almost a 1000 times normal volume and it's given up almost all its gains, is the stock broken or just a piece of crapola?
The news certainly sounded very good so why has it tanked off its high this morning?
Makes no sense
On December 12, 2022, Aptevo Therapeutics Inc. (“Aptevo” or the “Company”) announced that APVO436, in combination with venetoclax and azacytidine,
achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients. The data, which was presented in a poster session at the 64th American
Society of Hematology Annual Meeting and Exposition in New Orleans, also showed that APVO436, when given in combination with this standard-of-care
regimen, was observed to be generally safe and well tolerated.
Aptevo plans to initiate a Phase 2 trial in the second half of 2023 to further evaluate APVO436 in combination with venetoclax and azacitidine among frontline
and relapsed/refractory AML patients who are venetoclax treatment naïve.
Strong move on the commons this morning let's see if that translates into a strong move on the warrants.
Looking for some positive moves with today's news.
Run Run and don't look back just run harder and harder.
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
243
|
Created
|
08/02/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |